European asymmetries: A comparative analysis of German and UK biotechnology clusters

Science and Public Policy

Volumn 34, Issue 7, 2007, Pages 454-474

  Cooke, Philip N ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CAPITAL; COMPARATIVE STUDY; DRUG; ENTREPRENEUR; FIRM SIZE; INNOVATION; INTELLECTUAL PROPERTY RIGHTS;

CENTRAL EUROPE; EURASIA; EUROPE; GERMANY; UNITED KINGDOM; WESTERN EUROPE;

EID: 38149035210     PISSN: 03023427     EISSN: None     Source Type: Journal    
DOI: 10.3152/030234207X251425     Document Type: Article

References (34)

1. Baden-Württemberg Biotechnology Guide 2006 Stuttgart: GWZ.
2. BioGenTech 1998 BioGen Tech Atlas. Cologne: BioGenTech.
3. Biotechnology Scotland Source Book 2000 2006 Glasgow, Scottish Enterprise.
4. Casper, S and A Karamanos 2003 Commercialising science in Europe: the Cambridge biotechnology cluster. European Planning Studies, 11, 805-822.
5. Chesbrough, H 2003 Open Innovation. Boston: Harvard Business School Press.
6. Clarke, L 1998 Setting the pace. Pharmaceutical Forum, 2-6.
7. Cooke, P 2001 Biotechnology clusters in the UK (2001). Small Business Economics, 17, 43-59.
8. Cooke, P 2002 Knowledge Economies. London: Routledge.
9. Cooke, P 2004 The accelerating evolution of biotechnology clusters. European Planning Studies, 12, 915-920.
10. Cooke, P 2007 Growth Cultures: the Global Bioeconomy and its Bioregions. London: Routledge.
11. Cooke, P, C de Laurentis, F Tödtling and M Trippl (2007) Regional Knowledge Economies. London: Routledge.
12. Cortright, J and H Mayer 2002 Signs of Life: the Growth of Biotechnology Centres in the US. Washington DC: The Brookings Institute.
13. CRIC 2005 Estimating the Value of Biotechnological Healthcare to the UK Economy, Report to UK Government. Manchester: CRIC.
14. Dohse, D 1999 The BioRegio Contest: Results of an Empirical Investigation. Kiel: Institute of World Economics.
15. Dohse, D 2000 Technology policy and the regions: the case of the BioRegio contest. Research Policy, 9, 1111-1133.
16. Dorey, E 2003 Emerging market Medicon Valley: a hotspot for biotech affairs. BioResource, March. , last accessed 00 Month 0000.
17. DTI, Department of Trade and Industry 1998 Biotechnology in Germany: Report of an ITS Expert Mission. London: DTI/Foreign and Commonwealth Office.
18. ERBI, Eastern Regional Biotechnology Initiative 2005 ERBI Sourcebook. Cambridge: ERBI.
19. Ernst & Young 2005 The Power of Evolution: German Biotechnology Report. London: Ernst & Young.
20. Foray, D and C Freeman 1993 Technology and the Wealth of Nations: the Dynamics of Constructed Advantage. London: Pinter.
21. Giesecke, S 1999 Determinants of a Successful S&T Policy in a National System of Innovation. Vienna: University of Economics.
22. Howard, K 2003 Biotechs sue Columbia over fourth Axel patent. Nature Biotechnology, 21, 955-956.
23. Helpman, E ed. 1998 General Purpose Technologies and Economic Growth. Cambridge: MIT Press.
24. Kaiser, R 2003 Multi-level science policy and regional innovation: the case of the Munich cluster for pharmaceutical biotechnology. European Planning Studies, 11, 841-858.
25. Kaiser, R and M Liecke 2006 Recent Developments in the Four Leading German Biotechnology Clusters. Munich: Ludwig Maximilians University.
26. Kaufmann, D, D Schwartz, A Frenkel and D Shafer 2003 The role of location and regional networks for biotechnology firms in Israel. European Planning Studies, 11, 823-840.
27. Lawton Smith, H 2004 The biotechnology industry in Oxfordshire: enterprise and innovation. European Planning Studies, 12, 985-1002.
28. Mihell, D, D Kingham and M Stott (1997) The Development of the Biotechnology Sector in Oxfordshire: Implications for Public Policy. Oxford: Oxford Innovation 8.
29. Omland, N and Ernst, H 2004 Vitalisation of industry through the regional promotion of knowledge-intensive new firms - the case of German biotechnology. Paper to Japanese Institute for Labour Policy and Training conference on Globalisation and Revitalisation of Regional Employment: Comparison of Germany and Japan. March 26, Tokyo.
30. OBN, Oxford Bioscience Network 2005 Oxford Bioscience Cluster Report. Oxford: OBN.
31. Scottish Enterprise 2005 Biotechnology Sourcebook. Glasgow: Scottish Enterprise.
32. Smith, A 1776 An Inquiry into the Nature and Causes of the Wealth of Nations. London: Methuen.
33. Ward, M 2005 Strategy: decapitation. BioCentury, 13, A1-A4.
34. VINNOVA 2003 Swedish Biotechnology-Scientific Publications, Patenting and Industrial Development. Stockholm: VINNOVA Swedish Agency for Innovation Systems.